Coronavirus
Japan to pool $20bn with Europe, Canada for vaccine-buying fund
Smaller nations join forces to match US-China purchasing power
Pharmaceuticals
Coronavirus: Free to read
Coronavirus: Week of June 28 to July 4, Global cases top 11 million
Tokyo surge rises to over 120 cases; Philippines and India log biggest spikes
Business trends
Japan execs' million-dollar club shrinks for first time in 8 years
Pandemic cuts into results-based pay, but top earners still riding high
Markets
IPO stocks in Thailand and South Korea surge on market debuts
Investors snap up shares in drugmaker SK Biopharm and glove producer Sri Trang
Pharmaceuticals
BioNTech and Pfizer's COVID-19 vaccine shows potential in trial
Shares of drugmakers rise on news as world races to find cure
Coronavirus
Fujifilm partners with India's Dr. Reddy's to sell Avigan overseas
Dubai-based Global Response Aid also gets right to develop COVID treatment
Pharmaceuticals
SK Biopharm to make stock market debut with $800m IPO
Deal will be largest offering in South Korea in three years and boosts drug sector
Coronavirus
Japan's Eisai to launch clinical trial for coronavirus treatment
Drugmaker to use once-promising sepsis medication in 500-person test
Pharmaceuticals
Gilead puts COVID-19 drug remdesivir at $2,340 per patient
Critics argue for lower price since US taxpayers covered development costs
Pharmaceuticals
Rakuten's new cancer therapy heads toward Japan and world debut
CEO Mikitani says filing for light-based tumor-killing method is 'huge milestone'
